Supplementary Table S4 from The First-in-Human ENCIT01 Trial Comparing Second- versus Third-Generation L1CAM-specific CAR T Cells in Patients with Primary Refractory or Relapsed Neuroblastoma
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Table S4 – Toxicities Possibly, Probably or Definitely Related to First Infusion of CAR T Cells.
Authors: Navin Pinto, Annette Künkele, Catherine M. Albert, Mallory R. Taylor, Heidi B. Ullom, Nicholas A. Vitanza, Ashley L. Wilson, Bonnie L. Cole, Cecilia C.S. Yeung, Jocelyn H. Wright, Wenjun Huang, Jason Wendler, Kristy Seidel, Christopher Brown, Joshua Gustafson, Stephanie D. Rawlings-Rhea, Adam Beebe, Stephanie Mgebroff, Rebecca A. Gardner, Michael C. Jensen, Julie R. Park
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7213330320
Cites:
Cited by:
Related to: